Bionano Genomics vs Rapid Micro Biosystems
Rapid Micro Biosystems is the larger business, with $33.6m of revenue in fiscal 2025 against $28.5m for Bionano Genomics (1.2 times as much). Rapid Micro Biosystems grew faster (19.7% against -7.4%). Bionano Genomics kept more of each dollar of sales as profit: a net margin of -92.6% against -140.3%.
| Latest fiscal year | Bionano GenomicsBNGO, 2025 | Rapid Micro BiosystemsRPID, 2025 |
|---|---|---|
| Revenue | $28.5m | $33.6m |
| Revenue growth | -7.4% | 19.7% |
| Net income | −$26.4m | −$47.1m |
| Operating margin | -116.9% | — |
| Net margin | -92.6% | -140.3% |
| Return on equity | -66.2% | -86.8% |
| Free cash flow | −$16.3m | −$31.9m |
| Cash | $3.0m | $20.0m |
| Total debt | $0 | $18.9m |
| Debt to equity | 0.0% | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 97 | 171 |
| Market value | $14.1m | $34.2m |
| Price vs our value range | — | — |
| Moat score | 11 (Weak) | 12 (Weak) |
| Insider trades, 12 months | 2 buys, 0 sales | 0 buys, 14 sales |